New metabolites of thiabendazole and the metabolism of thiabendazole by mouse embryo in vivo and in vitro

https://doi.org/10.1016/0278-6915(91)90024-2Get rights and content

Abstract

Thiabendazole [2-(4′-thiazolyl)benzimidazole; TBZ], a teratogen in ICR mice, is known to be mainly metabolized to 5-hydroxy-TBZ (5-OH-TBZ) and its conjugates in domestic and laboratory animals. Besides the known metabolites of TBZ, 4-hydroxy-TBZ and 2-acetylbenzimidazole (ABI) were identified as new metabolites of TBZ in the urine of F344 rats and ICR mice. 5-OH-TBZ and ABI, as well as TBZ, were found in the embryos of ICR mice given TBZ orally on day 10 of gestation. In the whole-embryo culture system, 5-OH-TBZ and ABI in the medium, and TBZ, 5-OH-TBZ and ABI in the embryo were detected after 24 hr of culture in 25 or 50 mug TBZ/ml. However, the amount of metabolites in the embryo in vitro was very small compared with that detected in vivo, whereas the amount of TBZ was comparable. Furthermore, the mouse embryo homogenate, at organogenesis, metabolized TBZ to 5-OH-TBZ or ABI. The specific activity required by this homogenate to form 5-OH-TBZ or ABI was less than 11000 of that of the liver microsomal fraction. The results suggested that mouse embryos at organogenesis could metabolize TBZ, although most of the metabolites in the embryo in vivo came from the dam.

References (19)

There are more references available in the full text version of this article.

Cited by (17)

  • Modulation of immune functions, inflammatory response, and cytokine production following long-term oral exposure to three food additives; thiabendazole, monosodium glutamate, and brilliant blue in rats

    2021, International Immunopharmacology
    Citation Excerpt :

    Thus, TBZ can easily remain a pesticide residue in food products [11]. Various reports have shown the TBZ negative impacts on animals and humans, including thyroid disturbances [12], anemia [13], teratogenicity [12], kidney injury [14], hepatic damage [15], and cytogenotoxicity [16]. TBZ has earlier been revealed to boost immune reaction at small doses or in the immunosuppressed host but to be immunosuppressive at relatively high dosages [17,18].

  • The fungicide thiabendazole causes apoptosis in rat hepatocytes

    2016, Toxicology in Vitro
    Citation Excerpt :

    Parenchymal liver damage caused by thiabendazole has occasionally led to irreversible hepatic failure (FDA, 2003; EMA, 2004). Besides liver toxicity, thiabendazole causes damage to thyroid and developmental processes (Fujitani et al., 1991) and is a potent nephrotoxin, leading to severe kidney damage (Mizutani et al., 1990). The liver is the main site of metabolism of drugs and environmental pollutants, mostly by cytochrome P450 (CYP) isoenzymes, which convert these compounds into more hydrophilic and less toxic compounds that can be easily eliminated from the organism (Brown et al., 2008; Badal and Delgoda, 2014).

  • Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: A possible mechanism of thiabendazole toxicity

    2011, Toxicology in Vitro
    Citation Excerpt :

    Teratogenicity and carcinogenicity, possibly linked to the changes in gene expression mentioned above, have been associated with TBZ therapy. TBZ is a known teratogen to ICR mice and mouse embryos are capable of metabolizing TBZ to 5OH-TBZ (Fujitani et al., 1991). TBZ has been linked with alterations in cell cycle regulation following spindle disruption (Holden et al., 1980).

View all citing articles on Scopus
View full text